Mark William Lowdell

All filings by Mark William Lowdell on record concern Inmune Bio, Inc., in the capacity of senior executive. Over a trading history stretching from 11 September 2019 to 2 July 2026, the count stands at 10 filings.

In open-market terms, that means 2 purchases worth €129k on one side and 5 sales worth €570k on the other. The net balance comes to €441k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants and 1 option exercise.

The record was last updated on 7 July 2026 with an option exercise (€8,838) in Inmune Bio, Inc. The last insider purchase was made public on 24 April 2024, 928 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.